PL361691A1 - Nowe związki - Google Patents

Nowe związki

Info

Publication number
PL361691A1
PL361691A1 PL01361691A PL36169101A PL361691A1 PL 361691 A1 PL361691 A1 PL 361691A1 PL 01361691 A PL01361691 A PL 01361691A PL 36169101 A PL36169101 A PL 36169101A PL 361691 A1 PL361691 A1 PL 361691A1
Authority
PL
Poland
Prior art keywords
novel compounds
novel
compounds
Prior art date
Application number
PL01361691A
Other languages
English (en)
Inventor
Pankaj Agarwal
John P. Cogswell
Ying-Ta Lai
Shelby A. Martensen
Randall F. Smith
Jay C. Strum
Qing Xie
Original Assignee
Smithkline Beecham Corporation
Smithkline Beecham P.L.C.
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation, Smithkline Beecham P.L.C., Glaxo Group Limited filed Critical Smithkline Beecham Corporation
Publication of PL361691A1 publication Critical patent/PL361691A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL01361691A 2000-09-13 2001-09-13 Nowe związki PL361691A1 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23246300P 2000-09-13 2000-09-13
US23245500P 2000-09-13 2000-09-13
US23729300P 2000-10-02 2000-10-02
US24626900P 2000-11-07 2000-11-07
US25204900P 2000-11-20 2000-11-20

Publications (1)

Publication Number Publication Date
PL361691A1 true PL361691A1 (pl) 2004-10-04

Family

ID=27540000

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01361691A PL361691A1 (pl) 2000-09-13 2001-09-13 Nowe związki

Country Status (16)

Country Link
US (1) US20070238151A1 (pl)
EP (1) EP1317538A4 (pl)
JP (1) JP2004508825A (pl)
KR (1) KR20030033055A (pl)
CN (2) CN1474869A (pl)
AU (2) AU2001292619B2 (pl)
BR (1) BR0113820A (pl)
CA (1) CA2421303A1 (pl)
CZ (1) CZ2003722A3 (pl)
HU (1) HUP0400016A3 (pl)
IL (1) IL154725A (pl)
MX (1) MXPA03002180A (pl)
NO (1) NO20031141L (pl)
NZ (2) NZ534259A (pl)
PL (1) PL361691A1 (pl)
WO (1) WO2002022802A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166132A1 (en) * 1998-08-26 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU4880901A (en) * 2000-04-21 2001-11-07 Takeda Chemical Industries Ltd Novel insulin/igf/relaxin family polypeptides and dnas thereof
US20030166522A1 (en) * 2000-12-12 2003-09-04 Ketchum Karen A. Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
CN1252257C (zh) * 2001-03-02 2006-04-19 复旦大学 人类g型溶菌酶、其编码序列、制法及用途
US7223558B2 (en) 2001-07-11 2007-05-29 Bristol-Myers Squibb Company Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof
AU2002359815A1 (en) * 2001-12-19 2003-07-09 Immunex Corporation C-type lectin polypeptide, polynucleotide and methods of making and use thereof
WO2003091414A2 (en) * 2002-04-26 2003-11-06 Zymogenetics, Inc. Adipocyte complement related protein zacrp8
AU2002952993A0 (en) * 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
PL1606409T3 (pl) 2003-03-19 2011-02-28 Biogen Ma Inc Białko wiążące receptor Nogo
EP1608398A2 (en) * 2003-03-31 2005-12-28 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Use of dg931 protein for treating diabetes, obesity and metabolic syndrome
BR0318307A (pt) * 2003-05-21 2006-07-11 Ares Trading Sa polipeptìdeo, molécula de ácido nucleico purificado, vetor, célula hospedeira, ligante, composto, método para diagnosticar uma doença em um paciente, uso de um polipeptìdeo, composição farmacêutica, composição de vacina, métodos para tratar uma doença para monitorar o tratamento terapêutico de doença em um paciente, método para a identificação de um composto que é efetivo no tratamento e/ou diagnóstico de doença, kit, e, animal não-humano transgênico ou knockout
AU2004249193A1 (en) * 2003-06-20 2004-12-29 Amgen Inc. Gene amplification and overexpression in cancer
PT1776136E (pt) 2004-06-24 2012-12-05 Biogen Idec Inc Tratamento de estados que envolvem desmielinização
US9093121B2 (en) 2006-02-28 2015-07-28 The Invention Science Fund I, Llc Data management of an audio data stream
US10003762B2 (en) 2005-04-26 2018-06-19 Invention Science Fund I, Llc Shared image devices
SI1904104T1 (sl) 2005-07-08 2013-12-31 Biogen Idec Ma Inc. Protitelesa SP35 in njihova uporaba
EP2315779A2 (en) 2008-07-09 2011-05-04 Biogen Idec MA Inc. Compositions comprising antibodies to lingo or fragments thereof
CA2780678A1 (en) 2009-11-19 2011-05-26 Ou Solis Biodyne Compositions for increasing polypeptide stability and activity, and related methods
US9796780B2 (en) 2012-05-14 2017-10-24 Biogen Ma Inc. LINGO-2 antagonists for treatment of conditions involving motor neurons
WO2016112270A1 (en) 2015-01-08 2016-07-14 Biogen Ma Inc. Lingo-1 antagonists and uses for treatment of demyelinating disorders
CN119351338B (zh) * 2023-09-15 2026-01-23 士泽生物医药（苏州）有限公司 一种表达cd300ld的低免疫原性细胞及其制备方法
CN120699089A (zh) * 2024-03-25 2025-09-26 中国农业大学 一种具glp-1受体激动剂活性的乳清蛋白源降血糖肽的制备及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0997476A3 (en) * 1998-09-25 2000-07-19 Schering-Plough Antibodies to a mammalian Langerhans cell antigen and their uses
AU2001243142A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
US20020012967A1 (en) * 2000-03-10 2002-01-31 Holloway James L. Insulin homolog polypeptide zins4
AU4880901A (en) * 2000-04-21 2001-11-07 Takeda Chemical Industries Ltd Novel insulin/igf/relaxin family polypeptides and dnas thereof
JP3785029B2 (ja) * 2000-08-04 2006-06-14 株式会社山武 制御装置および制御方法
CA2431144A1 (en) * 2000-12-18 2002-08-01 Incyte Genomics, Inc. Cell adhesion proteins
WO2002068649A2 (en) * 2001-01-31 2002-09-06 Curagen Corporation Proteins and nucleic acids encoding same
US6783969B1 (en) * 2001-03-05 2004-08-31 Nuvelo, Inc. Cathepsin V-like polypeptides

Also Published As

Publication number Publication date
NO20031141D0 (no) 2003-03-12
CN1680441A (zh) 2005-10-12
MXPA03002180A (es) 2004-12-13
EP1317538A4 (en) 2005-04-06
WO2002022802A1 (en) 2002-03-21
NZ524328A (en) 2004-09-24
NO20031141L (no) 2003-05-09
JP2004508825A (ja) 2004-03-25
IL154725A0 (en) 2003-10-31
NZ534259A (en) 2006-05-26
CN1474869A (zh) 2004-02-11
CZ2003722A3 (en) 2004-03-17
CA2421303A1 (en) 2002-03-21
KR20030033055A (ko) 2003-04-26
AU9261901A (en) 2002-03-26
HUP0400016A2 (hu) 2004-04-28
HUP0400016A3 (en) 2006-01-30
US20070238151A1 (en) 2007-10-11
IL154725A (en) 2003-12-23
EP1317538A1 (en) 2003-06-11
AU2001292619B2 (en) 2006-01-12
BR0113820A (pt) 2003-06-24

Similar Documents

Publication Publication Date Title
AU7476301A (en) Novel compounds
EP1276755A4 (en) NEW COMPOUNDS
HUP0400016A2 (hu) Új vegyületek
GB0003019D0 (en) Novel compounds
GB0008464D0 (en) Novel compounds
EP1472352A4 (en) NEW COMPOUNDS
EP1343813A4 (en) NEW COMPOUNDS
AU7476401A (en) Novel compounds
EP1276866A4 (en) NEW COMPOUNDS
GB0004149D0 (en) Novel compounds
EP1299530A4 (en) NEW COMPOUNDS
GB0003636D0 (en) Novel compounds
GB0001898D0 (en) Novel compounds
GB0002402D0 (en) Novel compounds
GB0004196D0 (en) Novel compounds
EG22332A (en) Novel compounds
GB0004186D0 (en) Novel Compounds
GB0004188D0 (en) Novel Compounds
GB0002191D0 (en) Novel compounds
GB0019473D0 (en) Novel compounds
GB0006168D0 (en) Novel compounds
GB0006545D0 (en) Novel compounds
GB0006132D0 (en) Novel compounds
GB0008807D0 (en) Novel compounds
GB0005256D0 (en) Novel compounds

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)